For all those upset about the efficacy trials, let
Post# of 15624
(Total Views: 633)
Posted On: 05/09/2017 2:50:03 PM
For all those upset about the efficacy trials, let me remind you all of something.
The first thing was safety trials that should have the results public forthwith. The efficacy is a bonus. They are not only submitting them to the Israel FDA equivalent but to the FDA in the US. Do you realize that the FDA has never accepted any plant based medication for consideration?
In addition, since the results were so positive, OWC is in the process of getting this technology protected through the IP process. This is not a simple thing.
I did a trademark application years ago and it took almost 2 years to have it approved. And that was just a trademark. Patents are a whole other story.
And being that it's with plant based cannabis, it may be more difficult.
Good gosh, enjoy the summer, PPS will be up and down, and in the fall we should see an increase in price dramatically to make all happy.
If Ya'll that worried, sell out, take the loss and move on. I for one, even though in the red right now, expect some great gains by the end of 2017.
The first thing was safety trials that should have the results public forthwith. The efficacy is a bonus. They are not only submitting them to the Israel FDA equivalent but to the FDA in the US. Do you realize that the FDA has never accepted any plant based medication for consideration?
In addition, since the results were so positive, OWC is in the process of getting this technology protected through the IP process. This is not a simple thing.
I did a trademark application years ago and it took almost 2 years to have it approved. And that was just a trademark. Patents are a whole other story.
And being that it's with plant based cannabis, it may be more difficult.
Good gosh, enjoy the summer, PPS will be up and down, and in the fall we should see an increase in price dramatically to make all happy.
If Ya'll that worried, sell out, take the loss and move on. I for one, even though in the red right now, expect some great gains by the end of 2017.
(2)
(0)